Literature DB >> 25560991

Modulation of PPARγ and TNFα by emu oil and glycyrrhizin in ulcerative colitis.

Sri Nandhini Sethuraman1, Selvasubramanian Swaminathan, Shinu B Nelson, Preetha S Palaninathan, Tirumurugaan K Gopalan, Pandiyan Velayudham.   

Abstract

Ulcerative Colitis (UC) is an inflammatory bowel disorder that affects colon and rectum. Treatments in many UC patients remain variably effective and are associated with considerable adverse effects. So the present study was undertaken to explore the antiinflammatory effects of emu oil, glycyrrhizin, and combination of emu oil and glycyrrhizin in acetic acid-induced UC in rats. UC was induced by intracolonic instillation of 5% acetic acid in rats. Emu oil and glycyrrhizin were orally administered to test groups. Severity of colitis was scored macroscopically and microscopically. The levels of myeloperoxidase and antioxidant enzymes namely catalase, superoxide dismutase and glutathione peroxidase were assessed spectrophotometrically. Expressions of PPARγ and TNFα were studied by real-time PCR. Acetic acid caused severe damage to colon and rectum. Emu oil and glycyrrhizin were found to significantly reduce macroscopic and microscopic lesions and decrease levels of myeloperoxidase. There was a significant improvement of antioxidant levels in treatment groups compared to acetic acid group. Combination of emu oil and glycyrrhizin showed a markedly greater modulation of PPARγ and TNFα expression than emu oil and glycyrrhizin when administered alone. Combination of emu oil and glycyrrhizin might have had synergistic effects in regulating PPARγ and TNFα. Further studies on mechanism of action of emu oil and glycyrrhizin combination would pave the way to define possibility of this combination as effective in the management of UC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25560991     DOI: 10.1007/s10787-014-0226-8

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  25 in total

Review 1.  PPARs at the crossroads of lipid signaling and inflammation.

Authors:  Walter Wahli; Liliane Michalik
Journal:  Trends Endocrinol Metab       Date:  2012-06-14       Impact factor: 12.015

2.  Depleted mucosal antioxidant defences in inflammatory bowel disease.

Authors:  G D Buffinton; W F Doe
Journal:  Free Radic Biol Med       Date:  1995-12       Impact factor: 7.376

Review 3.  Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease.

Authors:  Kevin P Pavlick; F Stephen Laroux; John Fuseler; Robert E Wolf; Laura Gray; Jason Hoffman; Matthew B Grisham
Journal:  Free Radic Biol Med       Date:  2002-08-01       Impact factor: 7.376

4.  Selenium: biochemical role as a component of glutathione peroxidase.

Authors:  J T Rotruck; A L Pope; H E Ganther; A B Swanson; D G Hafeman; W G Hoekstra
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

5.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

6.  Anti-inflammatory activity of emu oils in rats.

Authors:  J M Snowden; M W Whitehouse
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 4.473

7.  Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs.

Authors:  C B Appleyard; J L Wallace
Journal:  Am J Physiol       Date:  1995-07

8.  Effects of Rhizophora mangle on Experimental Colitis Induced by TNBS in Rats.

Authors:  Felipe Meira de Faria; Anderson Luiz-Ferreira; Eduardo Augusto Rabelo Socca; Ana Cristina Alves de Almeida; Ricardo José Dunder; Luis Paulo Manzo; Marcelo Aparecido da Silva; Wagner Vilegas; Ariane Leite Rozza; Cláudia Helena Pellizzon; Lourdes Campaner Dos Santos; Alba Regina Monteiro Souza Brito
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-27       Impact factor: 2.629

9.  Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine.

Authors:  M W Whitehouse; A G Turner; C K Davis; M S Roberts
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 5.093

10.  Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy.

Authors:  Suzanne M Abimosleh; Cuong D Tran; Gordon S Howarth
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

View more
  2 in total

Review 1.  The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders.

Authors:  Camila Dos Santos Leite; Gabriel Alves Bonafé; Juliana Carvalho Santos; Carlos Augusto Real Martinez; Manoela Marques Ortega; Marcelo Lima Ribeiro
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

2.  Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB Pathway.

Authors:  HaiJing Zhang; GuangMing Song; ZhiHui Zhang; HuaChen Song; XiaoNan Tang; AnJun Deng; WenJie Wang; LianQiu Wu; HaiLin Qin
Journal:  Front Pharmacol       Date:  2017-09-05       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.